Real-World Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Database for Asciminib
The study sheds light on additional potential AEs associated with asciminib use, warranting further research to confirm these findings.
Authors
- Yaping Huang (ORCID: https://orcid.org/0000-0002-4465-372X)
- Chengjie Ke (ORCID: https://orcid.org/0009-0006-4160-1875)
- Qichun Nian
- Yan Chen (ORCID: https://orcid.org/0000-0002-1397-6358)
- Maohua Chen (ORCID: https://orcid.org/0000-0002-0812-2729)
- Zhijing Liu (ORCID: https://orcid.org/0009-0003-4235-1079)
- Dongzhi Wu
Institutions
- Fujian Medical University (CN)
- Fuzhou Second Hospital (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Fujian Provincial Hospital (CN)
- Comprehensive Clinical Research (US)
- Fuzhou University (CN)
Publication Details
- Journal
- Oncology
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1159/000540542
- Citations
- 5
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.27